Department of Molecular Biology, Max-Planck-Institute for Biophysical Chemistry, Göttingen, Germany.
Department of Molecular Epigenetics, Helmholtz Center Munich, Center of Integrated Protein Science, Munich, Germany.
Elife. 2017 Oct 10;6:e29736. doi: 10.7554/eLife.29736.
Gene transcription can be activated by decreasing the duration of RNA polymerase II pausing in the promoter-proximal region, but how this is achieved remains unclear. Here we use a 'multi-omics' approach to demonstrate that the duration of polymerase pausing generally limits the productive frequency of transcription initiation in human cells ('pause-initiation limit'). We further engineer a human cell line to allow for specific and rapid inhibition of the P-TEFb kinase CDK9, which is implicated in polymerase pause release. CDK9 activity decreases the pause duration but also increases the productive initiation frequency. This shows that CDK9 stimulates release of paused polymerase and activates transcription by increasing the number of transcribing polymerases and thus the amount of mRNA synthesized per time. CDK9 activity is also associated with long-range chromatin interactions, suggesting that enhancers can influence the pause-initiation limit to regulate transcription.
基因转录可以通过减少 RNA 聚合酶 II 在启动子近端区域的暂停时间来激活,但具体如何实现仍不清楚。在这里,我们使用“多组学”方法证明,聚合酶暂停的持续时间通常限制了人类细胞中转录起始的有效频率(“暂停-起始限制”)。我们进一步设计了一种人细胞系,使其能够特异性和快速抑制 P-TEFb 激酶 CDK9,CDK9 被认为与聚合酶暂停释放有关。CDK9 的活性降低了暂停时间,但也增加了有效的起始频率。这表明 CDK9 通过增加转录聚合酶的数量以及因此每时间合成的 mRNA 量,刺激暂停聚合酶的释放并激活转录。CDK9 的活性也与长程染色质相互作用有关,这表明增强子可以影响暂停-起始限制来调节转录。